Craven House Capital PLC Portfolio Update (9177R)
March 03 2023 - 1:15PM
UK Regulatory
TIDMCRV
RNS Number : 9177R
Craven House Capital PLC
03 March 2023
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED
UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014
WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL)
ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO
BE IN THE PUBLIC DOMAIN.
Craven House Capital plc
Portfolio Update
Craven House Capital plc ("Craven House" or the "Company"), the
AIM quoted investment company provides this update regarding the
following investee companies:
Stormfjord Ltd ("Stormfjord")
The Company has been informed that Stormfjord, the owner of
www.onebas.com raised $100,000 on 1st March 2023 at a valuation of
$28,000,000.
Craven House originally acquired a 29.9% stake in Onebas.com Ltd
(the previous legal entity under which the domain Onebas.com was
owned) on 13 March 2020 for a consideration of $1,600,000 via a
share subscription for 800,000 ordinary shares in the Company
priced at $10.00 per share. This valued Onebas.com Ltd at
$5.35m.
Following completion of the fundraising, Craven House's holding
of 29,900,000 shares represents 25.5% of Stomfjord.
Rosedog Ltd ("Rosedog")
The Company has been informed that Rosedog, the owner of
www.tvzinos.com raised $70,000 on 1st March 2023 at a valuation of
$28,000,000.
Craven House originally acquired a 29.9% stake in Rosedog on 13
March 2020 for a consideration of $1,600,000 via a share
subscription for 800,000 ordinary shares in the Company priced at
$10.00 per share. This valued Rosedog Ltd at $5.35m.
Following completion of the fundraising, Craven House's holding
of 29,900,000 shares represents 28.6% of Rosedog.
Bio Vitos Ltd ("Bio Vitos")
The Company has been informed that Bio Vitos raised $13,000 on
1st March 2023, at a valuation of $10,000,000.
Craven House originally acquired a 29.9% stake in Bio Vitos
(previously called YRRO Ltd) on 13 March 2020 for a consideration
of $1,600,000 via a share subscription for 800,000 ordinary shares
in the Company priced at $10.00 per share. This valued Bio Vitos at
$5.35m.
Following completion of the fundraising, Craven House's holding
of 14,708,700 shares represents 24.5% of Bio Vitos.
Ends
For further information please contact:
Craven House Capital Plc Tel: 0203 286 8130
Mark Pajak
www.Cravenhousecapital.com
Tel: 0203 286 8130
SI Capital Tel: 01483 413500
Broker
Nick Emerson
www.sicapital.co.uk
SPARK Advisory Partners Limited Tel: 0203 368 3550
Nominated Adviser
Matt Davis/James Keeshan
www.Sparkadvisorypartners.com
About Craven House Capital plc: The Company's Investing Policy
is primarily to invest in or acquire a portfolio of companies,
partnerships, joint ventures, businesses or other assets
participating in the e-Commerce sector.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PFUBIGDXSBGDGXX
(END) Dow Jones Newswires
March 03, 2023 13:15 ET (18:15 GMT)
Craven House Capital (LSE:CRV)
Historical Stock Chart
From Dec 2024 to Jan 2025
Craven House Capital (LSE:CRV)
Historical Stock Chart
From Jan 2024 to Jan 2025